The recurrence of NMO-ON was related to the ratio of CD19+ B cells in peripheral blood and the continuous high- or short-term increase in serum AQP4-Ab, and patients with NOS-Abs might tend to relapse early (within 6 months) after RTX induction. The gene discussed is CD19; the disease is neuromyelitis optica.